BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27925871)

  • 21. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
    Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
    Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
    Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
    Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
    Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
    Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
    Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dentate Nucleus Signal Intensity Decrease on T1-weighted MR Images after Switching from Gadopentetate Dimeglumine to Gadobutrol.
    Behzadi AH; Farooq Z; Zhao Y; Shih G; Prince MR
    Radiology; 2018 Jun; 287(3):816-823. PubMed ID: 29533723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
    Ichikawa S; Motosugi U; Omiya Y; Onishi H
    Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
    Lee JY; Park JE; Kim HS; Kim SO; Oh JY; Shim WH; Jung SC; Choi CG; Kim SJ
    PLoS One; 2017; 12(8):e0183916. PubMed ID: 28859167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
    Kanda T; Ishii K; Kawaguchi H; Kitajima K; Takenaka D
    Radiology; 2014 Mar; 270(3):834-41. PubMed ID: 24475844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
    Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
    Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
    Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
    Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
    Ozturk K; Nascene D
    Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
    Flood TF; Stence NV; Maloney JA; Mirsky DM
    Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
    Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
    Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
    Tamrazi B; Liu CJ; Cen SY; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 Oct; 289(1):188-194. PubMed ID: 29989524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
    Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
    Pozeg P; Forget J; Meuli RA; Maeder P
    Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.